Welcome to our dedicated page for Waterdrop news (Ticker: WDH), a resource for investors and traders seeking the latest updates and insights on Waterdrop stock.
Waterdrop Inc. reports recurring developments for its NYSE-listed American depositary shares and its technology platform for insurance and healthcare services. Company news centers on unaudited quarterly and fiscal results, insurance-related revenue, cash dividends, ADS repurchases, and annual Form 20-F reporting.
Operational updates also cover Waterdrop Medical Crowdfunding, including risk-control and donor-transparency systems, and the E-Find Platform, the company’s digital clinical trial solution for patient enrollment and drug-patient matching. Product and technology updates include insurance plan launches, data infrastructure, automated review tools, and medical knowledge graph applications.
Waterdrop (NYSE: WDH) appointed Ms. Qianfei Chang as an independent director, effective July 1, 2026, replacing Mr. Heping Feng.
She will chair the audit committee and join the compensation and nominating committees. Mr. Feng resigned for personal reasons, with no dispute or disagreement with the company reported.
Waterdrop (NYSE: WDH) reported unaudited Q1 2026 net operating revenue of RMB1,242.2 million, up 64.8% year-over-year, and net profit attributable to ordinary shareholders of RMB98.4 million, its 17th consecutive profitable quarter.
Insurance-related income rose 74.1% year-over-year, AI tools supported premium growth, E-Find clinical trial solutions revenue reached RMB24.2 million, and cumulative share repurchases totaled about 61.8 million ADSs.
Waterdrop (NYSE: WDH) reported unaudited Q1 2026 results with net operating revenue of RMB1,242.2 million, up 64.8% year-over-year but down 12.0% quarter-over-quarter. Insurance-related income rose 74.1% to RMB1,145.8 million.
Operating profit reached RMB80.0 million, net profit was RMB98.4 million, and cash position stood at RMB2,880.7 million. The company continued AI deployment, expanded clinical trial enrollment, and, by May 31, 2026, had repurchased 61.8 million ADSs for US$120.1 million and paid a US$10.8 million dividend.
Waterdrop (NYSE: WDH) will release its unaudited Q1 2026 financial results before U.S. markets open on Tuesday, June 16, 2026, for the quarter ended March 31, 2026.
Management will host an earnings conference call with Chinese and English listen-only lines and webcast replays.
Waterdrop (NYSE: WDH) filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the SEC on April 28, 2026. The report, including audited consolidated financial statements, is available on the company's investor relations website and the SEC's website.
Shareholders may request a free hard copy by contacting the IR department at IR@shuidi-inc.com.
Waterdrop (NYSE: WDH) reported strong Q4 and full‑year 2025 results: Q4 net operating revenue RMB1,411.2M (+105.5% YoY) and Q4 net profit attributable to shareholders RMB162.1M (+62.7% YoY). For 2025, revenue was RMB3,977.8M (+43.5% YoY) and net profit RMB568.9M.
The company held RMB3,249.0M cash at year-end, repurchased ~60.7M ADS by Feb 2026, and approved a ~US$10.8M cash dividend. Insurance operating profit was RMB644.9M; medical crowdfunding raised RMB72.3B for 3.68M patients. E-Find enrolled 14,555 patients into 1,611 trials.
Waterdrop (NYSE: WDH) reported strong fourth-quarter and full-year 2025 results and declared a cash dividend. Q4 net operating revenue rose 105.5% YoY to RMB1,411.2 million; Q4 net profit attributable to ordinary shareholders was RMB162.1 million, up 62.7% YoY. The company announced cumulative repurchases of ~60.7 million ADSs (~US$118.1 million) and a board‑approved cash dividend of ~US$10.8 million.
Management highlighted AI deployment across insurance, fraud controls for medical crowdfunding, and a patented intelligent drug‑patient matching technology supporting digital clinical trial growth.
Waterdrop (NYSE: WDH) will report unaudited fourth quarter and fiscal year 2025 results before U.S. markets open on March 25, 2026. Management will host an earnings conference call the same day at 8:00 AM ET (8:00 PM Beijing/Hong Kong).
Telephone dial-in numbers, interpretation lines, replay access through April 1, 2026, and a live/archived webcast on the company's investor relations site are provided for investors.
Waterdrop (NYSE: WDH) reported third-quarter 2025 unaudited results for the period ended Sept 30, 2025: net operating revenue RMB 974.9 million (+38.4% YoY) and net profit attributable to ordinary shareholders RMB 158.5 million (+60.1% YoY), marking the fifteenth consecutive profitable quarter.
Operating expenses fell to 39.6% of revenue, down 8.3 percentage points YoY. Since 2021, the company repurchased ~58.1 million ADSs through Nov 30, 2025. Insurance revenue grew to RMB 869.7 million (+44.8% YoY) with insurance operating profit RMB 176.4 million (+44% YoY). Medical crowdfunding raised RMB 71.2 billion for 3.61 million patients cumulatively.
Waterdrop (NYSE: WDH) reported unaudited Q3 2025 results on Dec 3, 2025: net operating revenue RMB974.9M (+38.4% YoY) and insurance-related income RMB869.7M (+44.8% YoY). Operating profit rose to RMB113.8M (+329.8% YoY) and net profit attributable to shareholders was RMB158.5M (+60.1% YoY). Cash position stood at RMB3,510.0M as of Sep 30, 2025. E-Find enrolled 13,282 patients cumulatively; medical crowdfunding facilitated RMB71.2B donated to 3.61M patients. Company repurchased ~58.1M ADSs for ~$113.4M through Nov 30, 2025.